According to Equasens's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.41. At the end of 2021 the company had a P/E ratio of 34.7.
Year | P/E ratio | Change |
---|---|---|
2021 | 34.7 | -26.77% |
2020 | 47.4 | 52.25% |
2019 | 31.1 | 7.13% |
2018 | 29.1 | 12.55% |
2017 | 25.8 | -2.54% |
2016 | 26.5 | 59.93% |
2015 | 16.6 | 6.59% |
2014 | 15.5 | 14.03% |
2013 | 13.6 | 20.3% |
2012 | 11.3 | 18.77% |
2011 | 9.53 | -13.39% |
2010 | 11.0 | 12.62% |
2009 | 9.77 | -0.17% |
2008 | 9.79 | -28.61% |
2007 | 13.7 | -10.04% |
2006 | 15.2 | 7146.46% |
2005 | 0.2104 | 41.61% |
2004 | 0.1486 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.